این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
دوشنبه 27 بهمن 1404
Medical Journal of Islamic Republic of Iran
، جلد ۳۱، شماره ۱، صفحات ۲۲۴-۲۲۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran
چکیده انگلیسی مقاله
Background: Hip, vertebral and wrist fractures are the most common consequences of osteoporosis. This study aimed at analyzing the cost-effectiveness of teriparatide (CinnoPar®), compared with alendronate and risedronate, in the treatment of women aged 60 and over with postmenopausal osteoporosis in Iran. Methods: A decision tree model with a 2-year time horizon was used to compare treatment with teriparatide (CinnoPar®) with the following treatment strategies: two years of treatment with alendronate and two years of treatment with risedronate in women aged 60 years and over or those at risk of osteoporosis. Cost per QALY was calculated for 3 treatment strategies from the model. After base case analysis, one-way sensitivity analysis was performed on key parameters of the model to assess their impact on the study results and the cost-effectiveness of different treatment strategies and the model robustness. TreeAge Pro 2006 software was used for modeling and data analysis. Results: Incremental cost-effectiveness ratio (ICER) of alendronate and teriparatide than risedronate (base treatment) were US$-2178.03 and US$483,783.67 per QALY, respectively. Therefore, the dominant and cost-effective treatment option was alendronate. In the one-way sensitivity analysis, the impact of annual 25% increase or decrease in the teriparatide cost on its ICER was remarkable. Also, reducing the discount rate from 0.03 to 0.0 had the greatest impact on the ICER of the teriparatide. Conclusion: The treatment strategy of teriparatide is more expensive than risedronate and alendronate and is associated with very little increase in QALYs. A significant reduction in teriparatide price and a limit in its use only for high-risk women and for acute and short-term treatment courses can contribute to its cost-effectiveness.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
امیرعلی عبادی فرد آذر | amir ali ebadi fard azar
medicine school, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
عزیز رضاپور | aziz rezapour
health management and economics research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
وحید علیپور | vahid alipour
health management and economics research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
علی سرابی آسیابر | ali sarabi asiabar
health management and economics research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
سراج الدین گری | serajaddin gray
department of health management and economics, school of public health, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
محمدرضا مبینی زاده | mohammadreza mobinizadeh
national institute for health research, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
مانی یوسف وند | mani yousefvand
department of health management and economics, school of public health, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
جلال عربلو | jalal arabloo
health management and economics research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
نشانی اینترنتی
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-3002-1&slc_lang=en&sid=en
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/18/article-18-421787.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
1
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات